Pregna-1,4-diene-3,20-dione, 11,21-bis(acetyloxy)-16,17-dihydroxy-, (11β,16α)- - Names and Identifiers
Name | 2-((8S,9S,10R,11S,13S,14S,16R,17S)-11-acetoxy-16,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
|
Synonyms | 2-((8S,9S,10R,11S,13S,14S,16R,17S)-11-acetoxy-16,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate Pregna-1,4-diene-3,20-dione, 11,21-bis(acetyloxy)-16,17-dihydroxy-, (11β,16α)- [2-[(8S,9S,10R,11S,13S,14S,16R,17S)-11-acetyloxy-16,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
|
CAS | 56723-09-2
|
EINECS | 611-417-8 |
Pregna-1,4-diene-3,20-dione, 11,21-bis(acetyloxy)-16,17-dihydroxy-, (11β,16α)- - Physico-chemical Properties
Molecular Formula | C25H32O8
|
Molar Mass | 460.52 |
Density | 1.28g/cm3 at 20℃ |
Boling Point | 600.4±55.0 °C(Predicted) |
Vapor Presure | 0-0Pa at 20-25℃ |
Appearance | Solid:particulate/powder |
pKa | 11.78±0.70(Predicted) |
Pregna-1,4-diene-3,20-dione, 11,21-bis(acetyloxy)-16,17-dihydroxy-, (11β,16α)- - Introduction
2-((8S,9S,10R,11S,13S,14S,16R,17s) -11-acetoxy-16, 17-dihydroxy-10, 13-Dimethyl-3-oxo-6, 7,8,9,10,11,12,13,14,15,16, ethyl 17-dodecyl-3H-cyclopenta [c] benzoalkan-17-yl)-2-oxoacetate is one compound. The following is a detailed description of its nature, use, formulation and safety information:
Nature:
-Molecular formula: C28H36O8
-Molecular weight: 500.59g/mol
-Appearance: White crystalline solid
-Melting Point: 179-184 ° C
-Solubility: Slightly soluble in water, soluble in organic solvents such as ethanol and dichloromethane
Use:
- 2-((8S,9S,10R,11S,13S,14S,16R,17s) -11-acetoxy-16, 17-dihydroxy -10, 13-Dimethyl-3-oxo-6, 7,8,9,10,11,12,13,14,15,16, ethyl 17-dodecyl-3H-cyclopentane [c] benzo-17-yl)-2-oxoacetate is an intermediate for the synthesis of steroids. It is often used in the preparation of drugs, in particular steroids with anti-inflammatory and immunomodulatory activity.
Preparation Method:
- 2-((8S,9S,10R,11S,13S,14S,16R,17s) -11-acetoxy-16, 17-dihydroxy -10, 13-Dimethyl-3-oxo-6, 7,8,9,10,11,12,13,14,15,16, 17-dodecyl-3H-cyclopentyl [c] benzoalkan-17-yl)-2-oxoethyl acetate can be prepared by chemical synthesis, including reaction steps such as acylation, esterification and oxoacidification, etc.
Safety Information:
- 2-((8S,9S,10R,11S,13S,14S,16R,17s) -11-acetoxy-16, 17-dihydroxy -10, 13-Dimethyl-3-oxo-6, 7,8,9,10,11,12,13,14,15,16, ethyl 17-dodecyl-3H-cyclopentane [c] benzo-17-yl)-2-oxoacetate poses a relatively low risk under correct use and storage conditions. However, as with any chemical, appropriate safe handling and protective measures should be followed, including the wearing of protective gloves, glasses and respiratory protective equipment. In addition, it should be kept away from fire sources and flammable materials, and used in well-ventilated places.
Last Update:2024-04-09 20:52:54